Pharma Two B

About:

Pharma Two B develops clinical products based on approved drugs, focusing on fixed-dose-combinations of two or more drugs for PD and cancer.

Website: http://www.pharma2b.com

Top Investors: Israel Biotech Fund, JK&B Capital, JVC, Generali Financial Holding, Michael Mittelman

Description:

Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. They focus on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505b2 approach). The company develops products in two therapeutic areas with great unmet needs - Parkinson's disease (PD) and Cancer.